Barbara Mirza

Cooley advised Automattic, a distributed company with 1,965 users in 93 countries speaking 119 different languages, on its acquisition of Beeper, a universal messaging application that combines 14 different chat networks in one inbox.

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Cooley advised Community, a short message service (SMS) customer engagement platform that connects businesses, brands, political and public figures, creators, musicians, celebrities and more, on its $25 million Series B financing. Partner Dave Young led the Cooley team.

Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.8 billion.

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.